Cantor Fitzgerald initiates Sagimet Biosciences with Overweight rating
Cantor Fitzgerald initiated Sagimet Biosciences with an Overweight rating and announced a $10.71/share price target.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.